Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case–Control Analysis
Frühe Integration chinesischer Medizinrehabilitation verbessert funktionelle Outcomes bei Schlaganfallpatient:innen: prospektive pragmatische Studie und verschachtelte Fall-Kontroll-Analyse
CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)
DOI: 10.1002/cns.71077 ↗Auf einen Blick
Bei Schlaganfallüberlebenden war eine CMR innerhalb von 6 Monaten nach dem Schlaganfall mit besseren funktionellen Ergebnissen verbunden als ein späterer Beginn. Auch ADL und TCMSSS verbesserten sich nach 24 Wochen.
Fragestellung
Verbessert eine frühe Integration individueller chinesischer Medizinrehabilitation innerhalb von 6 Monaten nach Schlaganfall die funktionellen Outcomes im Vergleich zu einem späteren Beginn?
Methode
Prospektive pragmatische Studie in 5 Gemeindezentren in Hongkong; 24 Wochen individualisierte CMR mit Akupunktur und chinesischer Kräutermedizin; post hoc verschachtelte Fall-Kontroll-Analyse mit 1:1 Propensity-Score-Matching.
Ergebnisse
398 Patient:innen wurden rekrutiert, 344 beendeten ≥ 75 % der Behandlung. Nach 24 Wochen verbesserten sich ADL (5,99; 95 %-KI 4,50–7,48), MMSE (1,21; 95 %-KI 0,87–1,55) und TCMSSS (−2,89; 95 %-KI −3,30 bis −2,47).
Schlussfolgerung der Autor:innen
Der Beginn der CMR innerhalb von 6 Monaten nach Schlaganfall verbesserte laut Autor:innen die funktionelle und neurologische Erholung im Vergleich zu einem späteren Beginn.
Kernaussagen
- ADL, MMSE und TCMSSS verbesserten sich nach 24 Wochen.
- Früher Beginn war ein unabhängiger Prädiktor für Ansprechen.
- Es wurden keine behandlungsbedingten unerwünschten Ereignisse beobachtet.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Klinische Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 07.08.2026. Verfasst von Jialing Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vincent V.C Woo Chinese Medicine Clinical Research Institute, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. Hauptthemen laut MEDLINE: Acupuncture Therapy, Drugs, Chinese Herbal, Medicine, Chinese Traditional, Recovery of Function. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bank of China (Hong Kong) (BOCHK), Vincent and Lily Woo Foundation, Andrew Hung Chinese Medicine Clinical Research Fund.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Chinese medicine (acupuncture and herbal medicine) is widely used in post‐stroke rehabilitation in Southeast Asia. However, evidence on its effectiveness and optimal timing remains inconclusive. This study aimed to determine whether early integration (≤ 6 months post‐stroke) of individualized Chinese medicine rehabilitation (CMR) improves functional outcomes compared with delayed integration (> 6 months) in stroke survivors.
Methods
This prospective pragmatic study enrolled stroke survivors aged 35–90 years from five Hong Kong community centers following hospital discharge. All subjects received a 24‐week individualized CMR scheme comprising acupuncture and Chinese herbal medicine (CHM) granules (administered thrice weekly for 24 weeks, totaling 72 sessions). Outcomes included the changes in activities of daily living (ADL; primary), mini‐mental state examination (MMSE), and traditional Chinese medicine syndrome score scale (TCMSSS). Effectiveness was assessed using linear mixed‐effect models for repeated measures. Multivariate logistic regression identified factors associated with treatment response. In a post hoc nested case–control analysis, early CMR integration (≤ 6 months post‐stroke) was compared with delayed integration (> 6 months) using 1:1 propensity score matching (age, sex, stroke number/type, baseline ADL, hypertension, diabetes, dyslipidaemia, acupuncture sessions, CHM duration).
Results
A total of 398 patients were recruited, of whom 344 (86.6%) completed ≥ 75% of the treatments (≥ 54 sessions). After 24 weeks of treatment, significant improvements were observed in ADL (mean change 5.99, 95% confidence interval [CI] 4.50 to 7.48), MMSE (1.21, 95% CI 0.87 to 1.55), and TCMSSS (−2.89, 95% CI −3.30 to −2.47). Multivariate logistic regression identified baseline ADL dependence (odds ratio [OR] 13.45, 95% CI 7.01 to 25.81), early CMR initiation (OR 2.03, 95% CI 1.23 to 3.35), and lower baseline TCMSSS (OR 0.94, 95% CI 0.91 to 0.98) as independent predictors of response. Kaplan–Meier analysis showed that patients with baseline ADL < 90 had markedly higher responder proportions (46.8% at 60 sessions, 53.6% at 72 sessions) than those with ADL ≥ 90 (9.4% and 12.3%, respectively; log‐rank P s < 0.001). Patients who initiated CMR within 6 months had significantly higher responder proportions at 72 sessions (42.9%) compared with those starting later (25.0%; log‐rank p = 0.005). Propensity score matching confirmed that early integration yielded superior ADL (mean difference 3.89, 95% CI 1.30 to 6.48; p = 0.003) and TCMSSS (−0.86, 95% CI −1.69 to −0.04; p = 0.041) outcomes at Week 24. CMR scheme was well‐tolerated, with no treatment‐related adverse events observed.
Conclusion
Initiating CMR within 6 months post‐stroke significantly enhances functional and neurological recovery compared with delayed initiation. These findings support integrating early, individualized CMR into standard stroke rehabilitation protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vincent V.C Woo Chinese Medicine Clinical Research Institute, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
- School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
- Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
- Chinese EQUATOR Centre, Hong Kong, China.
- Centre for Chinese Herbal Medicine Drug Development, Hong Kong Baptist University, Hong Kong, China.
ORCID-Profile: Jialing Zhang, Keyi Zhou, Chin Pong Ho, Zhilin Lin, Linda Ld Zhong
Förderung
- Bank of China (Hong Kong) (BOCHK)
- Vincent and Lily Woo Foundation
- Andrew Hung Chinese Medicine Clinical Research Fund
- InnoHK initiative of the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government
Zitieren
APA
Zhang, J., Ng, Y. W., Zhou, K., Fang, H. M., Wu, X., Chow, H. Y., Ho, C. P., Lin, Z., Cheung, C. H., Zhong, L. L., & Bian, Z. (2026). Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case–Control Analysis. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71077
Vancouver
Zhang J, Ng YW, Zhou K, Fang HM, Wu X, Chow HY, et al. Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case–Control Analysis. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71077
BibTeX
@article{Zhang2026,
author = {Zhang, Jialing and Ng, Yan Wa and Zhou, Keyi and Fang, Hao Ming and Wu, Xingyao and Chow, Ho Yan and Ho, Chin Pong and Lin, Zhilin and Cheung, Chun Hoi and Zhong, Linda Ld and Bian, Zhaoxiang},
title = {Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case–Control Analysis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {8},
doi = {10.1002/cns.71077}
}
EUVIMED